Transcatheter Aortic Valve Replacement: The Experience of One Brazilian Health Care Center

Autor: Fabiula Schwartz de Azevedo, Bruno Miranda Marques, Daniel Arthur Barata Kasal, Débora Holanda Gonçalves Paula, Andrey José de Oliveira Monteiro, Clara Weksler, Ana Paula Chedid Mendes, Alex dos Santos Felix, Luciano Herman Juaçaba Belém, Alexandre Siciliano Colafranceschi, Marcelo Goulart Correa, Valeria Gonçalves Silva
Rok vydání: 2018
Předmět:
Male
lcsh:Diseases of the circulatory (Cardiovascular) system
medicine.medical_specialty
medicine.medical_treatment
lcsh:Surgery
Hemodynamics
030204 cardiovascular system & hematology
Severity of Illness Index
Prosthesis
Transcatheter Aortic Valve Replacement
03 medical and health sciences
0302 clinical medicine
Valve replacement
Risk Factors
Internal medicine
medicine
Clinical endpoint
Humans
Prospective Studies
Aortic Valve Stenosis/surgery
Prospective cohort study
Aged
Aged
80 and over

Heart Valve Prosthesis Implantation
Ejection fraction
business.industry
Aortic Valve Stenosis
lcsh:RD1-811
General Medicine
medicine.disease
New York Heart Association Functional Classification
Stenosis
Treatment Outcome
Echocardiography
lcsh:RC666-701
Heart Valve Prosthesis
Cardiology
Female
Original Article
Surgery
Cardiology and Cardiovascular Medicine
business
Brazil
Zdroj: Brazilian Journal of Cardiovascular Surgery, Vol 33, Iss 1, Pp 1-7
Brazilian Journal of Cardiovascular Surgery, Volume: 33, Issue: 1, Pages: 1-7, Published: FEB 2018
Brazilian Journal of Cardiovascular Surgery
Brazilian Journal of Cardiovascular Surgery v.33 n.1 2018
Sociedade Brasileira de Cirurgia Cardiovascular (SBCCV)
instacron:SBCCV
ISSN: 1678-9741
DOI: 10.21470/1678-9741-2017-0117
Popis: Objective: Transcatheter aortic valve replacement has been an alternative to invasive treatment for symptomatic severe aortic stenosis in high risk patients. The primary endpoint was 30-day and 1-year mortality from any cause. Secondary endpoints were to compare the clinical and echocardiographic variation pre-and post- transcatheter aortic valve replacement, and the occurrence of complications throughout a 4-year follow-up period. Methods: This prospective cohort, nestled to a multicenter study (Registro Brasileiro de Implante de Bioprótese por Cateter), describes the experience of a public tertiary center in transcatheter aortic valve replacement. All patients who underwent this procedure between October 2011 and February 2016 were included. Results: Fifty-eight patients underwent transcatheter aortic valve replacement. The 30-day all-cause mortality was 5.2% (n=3) and after 1 year was 17.2% (n=10). A significant improvement in New York Heart Association functional classification was observed when comparing pre-and post- transcatheter aortic valve replacement (III or IV 84.4% versus 5.8%; P
Databáze: OpenAIRE